Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Medical, Continuing | 5 | 2016 | 132 | 0.820 |
Why?
|
| Decision Making | 3 | 2015 | 680 | 0.570 |
Why?
|
| Peer Influence | 1 | 2016 | 3 | 0.480 |
Why?
|
| Information Dissemination | 2 | 2016 | 195 | 0.480 |
Why?
|
| Communication | 2 | 2012 | 530 | 0.480 |
Why?
|
| Academic Success | 1 | 2016 | 22 | 0.470 |
Why?
|
| Review Literature as Topic | 1 | 2016 | 51 | 0.470 |
Why?
|
| Internet | 4 | 2015 | 417 | 0.450 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 112 | 0.440 |
Why?
|
| Interprofessional Relations | 1 | 2016 | 152 | 0.430 |
Why?
|
| Patient-Centered Care | 2 | 2014 | 228 | 0.370 |
Why?
|
| Multimedia | 1 | 2010 | 11 | 0.340 |
Why?
|
| Physicians | 2 | 2016 | 634 | 0.340 |
Why?
|
| Congresses as Topic | 2 | 2014 | 184 | 0.330 |
Why?
|
| Quality of Health Care | 2 | 2010 | 410 | 0.310 |
Why?
|
| Medical Informatics | 1 | 2011 | 106 | 0.310 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 434 | 0.290 |
Why?
|
| Social Media | 1 | 2011 | 118 | 0.290 |
Why?
|
| Academic Medical Centers | 2 | 2011 | 322 | 0.250 |
Why?
|
| Disasters | 1 | 2007 | 100 | 0.240 |
Why?
|
| Teaching | 1 | 2005 | 194 | 0.210 |
Why?
|
| Globins | 6 | 1986 | 24 | 0.190 |
Why?
|
| Faculty, Medical | 2 | 2016 | 267 | 0.160 |
Why?
|
| Transfection | 7 | 1991 | 960 | 0.140 |
Why?
|
| Teacher Training | 1 | 2016 | 9 | 0.120 |
Why?
|
| New York | 1 | 2016 | 69 | 0.120 |
Why?
|
| Transitional Care | 1 | 2015 | 17 | 0.120 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2015 | 69 | 0.110 |
Why?
|
| Focus Groups | 1 | 2016 | 227 | 0.110 |
Why?
|
| Learning | 2 | 2016 | 369 | 0.110 |
Why?
|
| Interpersonal Relations | 1 | 2016 | 221 | 0.110 |
Why?
|
| Societies, Scientific | 1 | 1993 | 25 | 0.100 |
Why?
|
| Gene Expression Regulation | 6 | 1988 | 2344 | 0.100 |
Why?
|
| Patient Education as Topic | 2 | 2015 | 460 | 0.100 |
Why?
|
| Transition to Adult Care | 1 | 2015 | 134 | 0.100 |
Why?
|
| Patient Participation | 1 | 2015 | 244 | 0.100 |
Why?
|
| Science | 1 | 1993 | 36 | 0.100 |
Why?
|
| Research | 1 | 2014 | 266 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2016 | 820 | 0.100 |
Why?
|
| Acetyltransferases | 3 | 1987 | 72 | 0.090 |
Why?
|
| Health Behavior | 1 | 2015 | 390 | 0.090 |
Why?
|
| Program Development | 1 | 1993 | 184 | 0.090 |
Why?
|
| Humans | 27 | 2016 | 130912 | 0.090 |
Why?
|
| Decision Support Techniques | 2 | 2015 | 296 | 0.090 |
Why?
|
| Staff Development | 1 | 2011 | 47 | 0.090 |
Why?
|
| Medication Adherence | 1 | 2014 | 333 | 0.080 |
Why?
|
| Genes | 3 | 1990 | 308 | 0.080 |
Why?
|
| Models, Educational | 1 | 2011 | 75 | 0.080 |
Why?
|
| Health Communication | 1 | 2011 | 31 | 0.080 |
Why?
|
| Suppression, Genetic | 1 | 1990 | 40 | 0.080 |
Why?
|
| Health Services Research | 1 | 2010 | 177 | 0.080 |
Why?
|
| Surveys and Questionnaires | 2 | 2016 | 4007 | 0.070 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 1986 | 12 | 0.070 |
Why?
|
| Cloning, Molecular | 2 | 1987 | 785 | 0.070 |
Why?
|
| Health Policy | 1 | 2010 | 225 | 0.070 |
Why?
|
| Louisiana | 1 | 2007 | 135 | 0.070 |
Why?
|
| Plasmids | 7 | 1991 | 455 | 0.060 |
Why?
|
| Self-Evaluation Programs | 1 | 2006 | 2 | 0.060 |
Why?
|
| Self-Assessment | 1 | 2006 | 59 | 0.060 |
Why?
|
| Family Practice | 1 | 2005 | 86 | 0.060 |
Why?
|
| Renin | 2 | 1983 | 76 | 0.050 |
Why?
|
| Leukemia | 2 | 1984 | 374 | 0.050 |
Why?
|
| Hyperlipidemias | 1 | 2005 | 188 | 0.050 |
Why?
|
| Cell Line | 8 | 1989 | 2596 | 0.050 |
Why?
|
| Hypolipidemic Agents | 1 | 2005 | 194 | 0.050 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 1892 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 2636 | 0.050 |
Why?
|
| Microcirculation | 1 | 1983 | 111 | 0.050 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 3 | 1987 | 59 | 0.050 |
Why?
|
| HeLa Cells | 5 | 1991 | 694 | 0.040 |
Why?
|
| Aorta | 1 | 1983 | 534 | 0.040 |
Why?
|
| Metabolic Syndrome | 1 | 2003 | 359 | 0.040 |
Why?
|
| Mass Screening | 1 | 2005 | 824 | 0.040 |
Why?
|
| RNA | 3 | 1991 | 531 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2006 | 1041 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2005 | 896 | 0.040 |
Why?
|
| Texas | 1 | 2007 | 3604 | 0.040 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 3 | 1985 | 8 | 0.030 |
Why?
|
| Diet | 1 | 2003 | 1115 | 0.030 |
Why?
|
| Endonucleases | 3 | 1985 | 50 | 0.030 |
Why?
|
| Transcription, Genetic | 6 | 1991 | 1396 | 0.030 |
Why?
|
| Receptors, Interleukin-2 | 3 | 1989 | 40 | 0.030 |
Why?
|
| Mammography | 1 | 2015 | 130 | 0.030 |
Why?
|
| Community Participation | 1 | 2014 | 43 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2014 | 123 | 0.030 |
Why?
|
| Base Sequence | 3 | 1991 | 2781 | 0.030 |
Why?
|
| Women | 1 | 1993 | 17 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2003 | 1408 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1993 | 135 | 0.020 |
Why?
|
| Education | 1 | 1993 | 109 | 0.020 |
Why?
|
| DNA | 2 | 1989 | 1444 | 0.020 |
Why?
|
| Forecasting | 1 | 1993 | 364 | 0.020 |
Why?
|
| United States | 3 | 2011 | 11716 | 0.020 |
Why?
|
| Role | 1 | 2011 | 28 | 0.020 |
Why?
|
| Minority Groups | 1 | 1993 | 256 | 0.020 |
Why?
|
| RNA, Ribosomal | 1 | 1991 | 52 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 1990 | 768 | 0.020 |
Why?
|
| Cell Cycle | 2 | 1990 | 600 | 0.020 |
Why?
|
| Diffusion of Innovation | 1 | 2011 | 84 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 1990 | 56 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 1225 | 0.020 |
Why?
|
| DEAE-Dextran | 1 | 1989 | 5 | 0.020 |
Why?
|
| Dextrans | 1 | 1989 | 45 | 0.020 |
Why?
|
| Interferon Type I | 1 | 1990 | 111 | 0.020 |
Why?
|
| Butyrates | 1 | 1989 | 41 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1989 | 249 | 0.020 |
Why?
|
| Genetic Vectors | 2 | 1989 | 900 | 0.020 |
Why?
|
| Canada | 1 | 2009 | 322 | 0.020 |
Why?
|
| Schools, Medical | 1 | 2009 | 110 | 0.020 |
Why?
|
| Cell Division | 1 | 1990 | 723 | 0.020 |
Why?
|
| Female | 5 | 2015 | 70740 | 0.020 |
Why?
|
| Genetic Markers | 1 | 1989 | 605 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 2 | 1985 | 74 | 0.020 |
Why?
|
| DNA Replication | 1 | 1990 | 358 | 0.020 |
Why?
|
| Data Collection | 1 | 2009 | 372 | 0.020 |
Why?
|
| Cell Separation | 1 | 1988 | 221 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1989 | 421 | 0.020 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1987 | 37 | 0.020 |
Why?
|
| Carbon Radioisotopes | 1 | 1987 | 68 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1987 | 46 | 0.020 |
Why?
|
| Cell Survival | 1 | 1989 | 850 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 3799 | 0.020 |
Why?
|
| Gene Expression | 1 | 1989 | 1500 | 0.010 |
Why?
|
| Adult | 3 | 2015 | 31533 | 0.010 |
Why?
|
| Interphase | 1 | 1985 | 35 | 0.010 |
Why?
|
| Fetal Hemoglobin | 1 | 1985 | 26 | 0.010 |
Why?
|
| Operon | 1 | 1985 | 49 | 0.010 |
Why?
|
| Hemoglobinopathies | 1 | 1985 | 17 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1983 | 199 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1983 | 153 | 0.010 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2003 | 32 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 1983 | 16 | 0.010 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1982 | 45 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1982 | 155 | 0.010 |
Why?
|
| Male | 4 | 2015 | 64819 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1990 | 1611 | 0.010 |
Why?
|
| Antibodies | 1 | 1983 | 357 | 0.010 |
Why?
|
| Binding Sites | 1 | 1985 | 1200 | 0.010 |
Why?
|
| Dietary Proteins | 1 | 2003 | 215 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 10037 | 0.010 |
Why?
|
| Animals | 6 | 1989 | 34275 | 0.010 |
Why?
|
| Swine | 1 | 1983 | 1188 | 0.010 |
Why?
|
| Alleles | 1 | 1984 | 1705 | 0.010 |
Why?
|
| Aged | 2 | 2014 | 21134 | 0.010 |
Why?
|
| Rats | 1 | 1983 | 3457 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 20812 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 28730 | 0.010 |
Why?
|
| Thymidine | 1 | 1991 | 52 | 0.010 |
Why?
|
| RNA Polymerase III | 1 | 1991 | 41 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 260 | 0.010 |
Why?
|
| Methionine | 1 | 1991 | 96 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1991 | 350 | 0.000 |
Why?
|
| Precipitin Tests | 1 | 1989 | 137 | 0.000 |
Why?
|
| Eukaryotic Cells | 1 | 1989 | 30 | 0.000 |
Why?
|
| Colchicine | 1 | 1989 | 40 | 0.000 |
Why?
|
| Butyric Acid | 1 | 1989 | 7 | 0.000 |
Why?
|
| Cell Membrane Permeability | 1 | 1989 | 67 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1989 | 141 | 0.000 |
Why?
|
| Gene Amplification | 1 | 1989 | 228 | 0.000 |
Why?
|
| Simian virus 40 | 1 | 1989 | 190 | 0.000 |
Why?
|
| Electrophysiology | 1 | 1989 | 252 | 0.000 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 1988 | 5 | 0.000 |
Why?
|
| Mice | 1 | 1986 | 18408 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1988 | 71 | 0.000 |
Why?
|
| Magnetics | 1 | 1988 | 31 | 0.000 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1989 | 272 | 0.000 |
Why?
|
| Antigens, Surface | 1 | 1988 | 116 | 0.000 |
Why?
|
| Receptors, Immunologic | 1 | 1988 | 119 | 0.000 |
Why?
|
| RNA, Messenger | 2 | 1983 | 2575 | 0.000 |
Why?
|
| Viral Proteins | 1 | 1988 | 339 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1989 | 1217 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1991 | 3610 | 0.000 |
Why?
|
| Deoxyribonuclease HpaII | 1 | 1985 | 8 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1989 | 861 | 0.000 |
Why?
|
| Azacitidine | 1 | 1985 | 51 | 0.000 |
Why?
|
| Cytarabine | 1 | 1985 | 100 | 0.000 |
Why?
|
| Hydroxyurea | 1 | 1985 | 88 | 0.000 |
Why?
|
| Hemin | 1 | 1983 | 14 | 0.000 |
Why?
|
| Kinetics | 1 | 1985 | 1101 | 0.000 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 1982 | 29 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1988 | 2965 | 0.000 |
Why?
|
| Nerve Tissue Proteins | 1 | 1988 | 1123 | 0.000 |
Why?
|
| Kidney | 1 | 1988 | 1300 | 0.000 |
Why?
|
| Mutation | 1 | 1991 | 6143 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1982 | 1352 | 0.000 |
Why?
|